Of more than $3B recovered by the federal government in fiscal year 2019 from fraud and false claims, 87% involved the healthcare industry, announced the Department […]
With new Commissioner Stephen Hahn at the lead, the FDA faces several important pressures as it kicks off the year. From not erecting too many barriers […]
Solid Biosciences is laying off about 37 of its 111 employees, including Chief Operating Officer Alvaro Amorrortu and Chief Medical Officer Jorge Quiroz. The company is […]
Eli Lilly will invest about $470M and create 460 jobs at their new injectable drug and device plant in Durham, North Carolina. The company expects to […]
EQRx, led by veteran biotech venture capitalist Alexis Borisy, is committed to inventing and introducing new drugs at “radically different” prices than what brand-name drugmakers charge. […]
CHANGING THE PARADIGM OF CANCER DIAGNOSIS When Suman Shirodkar, MBBS, Ph.D., became the CEO of Cambridge Epigenetix Ltd. in 2018, she brought several decades of diverse […]
By Robert Ruth, Vice President & Managing Director, Ashton Tweed See this article on LinkedIn. The advancement and implementation of artificial intelligence (AI) has been a […]
Thanks to EvaluatePharma, FiercePharma was able to assemble a list of the top 10 most-anticipated new drug launches of 2020 based on estimated global sales in […]